NAS:MGNX (USA) Also Trade In: Germany

Macrogenics Inc $ 30.52 -0.16 (-0.52%)

Volume:
423,168
Avg Vol (1m):
1,916,928
Market Cap $:
1.50 Bil
Enterprise Value $:
1.36 Bil
P/E (TTM):
0.00
P/B:
7.87
Warning! GuruFocus has detected 3 Severe warning signs with MGNX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for MGNX (Macrogenics) from 2013 to Jul 11 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Macrogenics stock (MGNX) PE ratio as of Jul 11 2020 is 0. More Details

Macrogenics PE Ratio (TTM) Chart

EMBED

Macrogenics PE Ratio (TTM) Historical Data

Total 1245
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Macrogenics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-07-120.0 2020-05-110.0
2020-07-100.0 2020-05-080.0
2020-07-090.0 2020-05-070.0
2020-07-080.0 2020-05-060.0
2020-07-070.0 2020-05-050.0
2020-07-060.0 2020-05-040.0
2020-07-030.0 2020-05-010.0
2020-07-020.0 2020-04-300.0
2020-07-010.0 2020-04-290.0
2020-06-300.0 2020-04-280.0
2020-06-290.0 2020-04-270.0
2020-06-260.0 2020-04-240.0
2020-06-250.0 2020-04-230.0
2020-06-240.0 2020-04-220.0
2020-06-230.0 2020-04-210.0
2020-06-220.0 2020-04-200.0
2020-06-190.0 2020-04-170.0
2020-06-180.0 2020-04-160.0
2020-06-170.0 2020-04-150.0
2020-06-160.0 2020-04-140.0
2020-06-150.0 2020-04-130.0
2020-06-120.0 2020-04-100.0
2020-06-110.0 2020-04-090.0
2020-06-100.0 2020-04-080.0
2020-06-090.0 2020-04-070.0
2020-06-080.0 2020-04-060.0
2020-06-050.0 2020-04-030.0
2020-06-040.0 2020-04-020.0
2020-06-030.0 2020-04-010.0
2020-06-020.0 2020-03-310.0
2020-06-010.0 2020-03-300.0
2020-05-290.0 2020-03-270.0
2020-05-280.0 2020-03-260.0
2020-05-270.0 2020-03-250.0
2020-05-260.0 2020-03-240.0
2020-05-250.0 2020-03-230.0
2020-05-220.0 2020-03-200.0
2020-05-210.0 2020-03-190.0
2020-05-200.0 2020-03-180.0
2020-05-190.0 2020-03-170.0
2020-05-180.0 2020-03-160.0
2020-05-150.0 2020-03-130.0
2020-05-140.0 2020-03-120.0
2020-05-130.0 2020-03-110.0
2020-05-120.0 2020-03-100.0

Macrogenics PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » Biotechnology NAICS : 325412 NAICS : 2834
Traded in other countries M55.Germany MGNX.USA
Address 9704 Medical Center Drive, Rockville, MD, USA, 20850
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them.